Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

A Preemption Comeback? Merck Wins An Important Ruling
Pharmalot
Monday, July 8, 2013 - 11:18am
tags:
Merck, Wyeth, Fosamax
Botox Gets $10 Billion Cheaper for Acquirers: Real M&A
Bloomberg
Monday, July 8, 2013 - 11:14am
tags:
M&A, Allergan, Botox, Merck, GSK, Nestle
Inovio says H7N9 vaccine protects 100% of vaccinated animals in study
Yahoo/Fly on the Wall
Monday, July 8, 2013 - 11:13am
tags:
Inovio, vaccines, Flu, flu vaccines, H7N9
The Best- And Worst-Performing Biotech Stocks, June 28 to July 5
Forbes
Monday, July 8, 2013 - 11:02am
tags:
biotech, ONYX Pharmaceuticals, Celldex, Novavax, Puma Biotechnology, Endocyte, Alnylam, Bluebird Bio, Dyax, Medivation, Clovis Oncology, Achillion, Insmed, Arena Pharmaceuticals, Avanir, Receptos, Synergy Pharmaceuticals, ChemoCentryx, Idenix, MiMedx, Portola Pharmaceuticals
Ohr Pharma Plans Regeneron Eye-Drug Rival as Patients Recruited
Bloomberg
Monday, July 8, 2013 - 10:59am
tags:
Ohr Pharmaceutical, Regeneron, Squalamine Eye Drops, wet age-related macular degeneration, Roche
Is Novavax On The Fast Track To Profits?
Seeking Alpha
Monday, July 8, 2013 - 10:58am
tags:
Novavax, RSV
Questcor: Near The Tipping Point
Seeking Alpha
Monday, July 8, 2013 - 10:57am
tags:
Questcor, Acthar
Novartis' psoriasis drug superior to Enbrel in study
Reuters
Monday, July 8, 2013 - 10:39am
tags:
Novartis, psoriasis, Enbrel, secukinumab
[video]Inhaled Insulin: Biotech Triumph or Future Flop?
Motley Fool
Monday, July 8, 2013 - 10:37am
tags:
inhaled insulin, Afrezza, MannKind, diabetes
A New Obesity Drug Faces The Weight Of History
Forbes
Monday, July 8, 2013 - 10:33am
tags:
obesity, Eisai, Arena Pharmaceuticals, Belviq
Lilly CEO returns after May aorta surgery
Yahoo/AP
Monday, July 8, 2013 - 9:44am
tags:
John Lechleiter, Pharma CEOs, Eli Lilly
Eli Lilly and Company and Boehringer Ingelheim announce regulatory submission for new insulin glargine biosimilar product
Yahoo
Monday, July 8, 2013 - 9:43am
tags:
diabetes, Eli Lilly, Boehringer Ingelheim, Europe, LY2963016, long-acting insulin, biosimilars
GSK examines Botox sales tactics used in China
Reuters
Monday, July 8, 2013 - 9:41am
tags:
GSK, Botox, China
Takeda Withdraws MAA for Omontys in Europe
NASDAQ
Saturday, July 6, 2013 - 12:30pm
tags:
Takeda, Omontys, chronic kidney disease
How Much Is Onyx Pharmaceuticals, Inc. (ONXX) Really Worth?
Insider Monkey
Saturday, July 6, 2013 - 12:29pm
tags:
ONYX Pharmaceuticals, M&A, Amgen
Impax Challenges Toviaz Patent
Yahoo/Zacks
Saturday, July 6, 2013 - 12:07pm
tags:
Impax, Toviaz, Pfizer, generics, lawsuits
Why You Should Buy This European Healthcare Company
Motley Fool
Saturday, July 6, 2013 - 12:03pm
tags:
GSK
Merck a Top Socially Responsible Dividend Stock With 3.7% Yield (MRK)
Forbes
Saturday, July 6, 2013 - 12:01pm
tags:
Merck
Amgen Stirs the Pot in the Cancer-Related Sector
Motley Fool
Saturday, July 6, 2013 - 12:00pm
tags:
Amgen, ONYX Pharmaceuticals, M&A
Symplmed Wins Rights from XOMA
Yahoo/Zacks
Saturday, July 6, 2013 - 11:59am
tags:
Symplmed Pharmaceuticals, Xoma, Aceon, hypertension

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.